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Abstract
A new analytical method based on solvent extraction, followed by continuous solid-phase
extraction (SPE) clean-up using a polymeric sorbent, was demonstrated to be applicable for
the detection of ivermectin in complex biological matrices of dung beetles (hemolymph,
excreta or dry tissues) using liquid chromatography combined with positive electrospray ion-
ization tandem mass spectrometry (LC/ESI+–MS/MS). Using a signal-to-noise ratio of 3:1,
the limit of detection (LOD) in the insect matrices at trace levels was 0.01 ng g–1 and the limit
of quantification (LOQ) was 0.1 ng g–1. The proposed method was successfully used to
quantitatively determine the levels of ivermectin in the analysis of small samples in in vivo
and post mortem samples, demonstrating the usefulness for quantitative analyses that are
focused on future pharmacokinetic and bioavailability studies in insects and the establish-
ment of a new protocol to study the impact of ivermectin on non-target arthropods such as
dung beetles and other insects that are related with the “dung community”. Because satis-
factory precision and accuracy values were obtained in both in vivo matrices, we suggest
that the method can be consistently used for quantitative determinations that are focused on
future pharmacokinetic and bioavailability studies in insects. Furthermore, this new analyti-
cal method was successfully applied to biological samples of dead dung beetles from the
field suggesting that the method can be used to establish a new routine analysis of ivermec-
tin residues in insect carcasses that is applied to complement typical mortality tests.
Introduction
Avermectins are macrocyclic lactone derivatives that are produced during the fermentation of
Streptomyces avermitilis. Abamectin and ivermectin are the two most widely used compounds
in the avermectins group. Ivermectin is an antiparasitic drug used in veterinary applications
for the control or eradication of parasites in mammals [1–3]. It has been the mainstay of live-
stock parasite control since the early 1980s, and over the last decade it has been increasingly
used to eradicate several human filarial parasite species [4,5]. Ivermectin has a high molecular
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weight (MW 860–874), and it has a 16-membered macrocyclic ring that contains disaccharide
components. It comprises a mixture of two homologous compounds, 22,23-dihydroavermec-
tin B1a (>80%) and 22,23-dihydroavermectin B1b (<20%) [6,7]. The use of ivermectin is toxic
to nervous and growth systems, and it is highly effective at extremely low dose levels (0.2–0.5
mg kg–1) against nematode and arthropod species in cattle, sheep, pigs and horses [8–10].
Ivermectin can be available in the form of an injectable solution, which is applied topically;
it is highly lipophilic and tends to deposit and accumulate in fat tissue, which could acts as a
drug reservoir [11]. The parent H2B1a component represents the major fraction of residue in
all animal species, and the majority of the dose given to the animal is excreted relatively unal-
tered in faeces [12]. Numerous field studies have reported strong non-target effects of ivermec-
tin on beneficial arthropods such as the arthropod community that is responsible for
decomposing livestock dung, such as dung beetles [10,12,13]. This focus is explained partly by
the high persistence of these compounds, partly by their toxicity at extremely low concentra-
tions, and partly by their mode of action; for example, impacting the nervous system of adult
and larval insects [12]. Therefore, the widespread use of these antiparasitic drugs could present
a potential risk to non-pest insects. A recent study showed that mature dung beetles feeding
on dung, even at low concentrations of ivermectin, experience an acute toxicity that alters sen-
sorial and locomotor capacities and consequently, it prevents the performance of normal bio-
logical activities such as food detection, interspecific communication, locomotion and
interaction with the environment. These results suggest that the decline of several populations
of dung beetles that has occurred across Europe could be related to the harmful effects of
chemical contamination in dung due to the effects of macrocyclic lactone derivatives [14]. For
this reason, the survival time of dung beetles decreases drastically as the amount of ingested
ivermectin increases [14]. Consequently, in sites where ivermectin is used as a preventive vet-
erinary medical product, a large number of dead beetles are found in the ground in close prox-
imity to the dung of treated cattle (JRV, personal observations).
Several analytical methods have been developed for the determination or quantification of
ivermectin in different matrices, including extraction and clean-up procedures and detection
methods (see Table 1 for a review). The methods that are used to analyze ivermectin include
thin layer chromatography, immunochemical methods, gas chromatography-mass spectrome-
try (GC–MS) and liquid chromatography (LC) with UV detection, fluorescence detection
(FLD) and mass spectrometry (MS) [15–30]. However, GC–MS and LC–FLD require derivati-
zation of the compounds prior to detection [31]. This additional step is time consuming as
well as labor intensive. Recently, a liquid chromatography electrospray ionization (LC–ESI+–
MS/MS) method was used. The method is direct and the analytes can be analyzed in the same
matrix without the need for derivatization [16,23]. Solid phase extraction (SPE) is commonly
used as a sample preparation method for several analytical procedures [32,33]. However, in
order to use a SPE approach for a broad range of matrix, having different physical and chemi-
cal properties, the choice of a single cation-exchange material for the clean-up SPE is limited
[34]. A preconcentration step by solid-phase extraction (SPE) and liquid chromatographic sep-
aration coupled to mass spectrometry enables very selective and sensitive detection, which
makes it a potential alternative to traditional methods. Continuous solid phase extraction is a
standard procedure and it has been used for the detection of pharmaceuticals in biological
samples [35] or pesticides in drinking water [36].
The present study is focused on the development of a simple detection method without
derivatization and further clean-up for ivermectin in insect-derived biological samples using
continuous solid phase extraction and LC-ESI-MS. The aim of the current work was to develop
a reliable and sensitive method for the routine analysis of ivermectin from various matrices
(hemolymph, insect excretes and dry insect carcasses) and there are two different goals. The
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first goal is to quantify the ivermectin concentration from in vivo samples such as hemolymph
or excretes from living beetles to establish future studies about the pharmacokinetics and bio-
availability of ivermectin in dung beetles. For this purpose, the model species was Scarabaeus
cicatricosus Lucas, 1846, which was selected due to its local abundance and functional rele-
vance in Mediterranean ecosystems [14]. The second goal is to describe a simple extraction
procedure that is applicable to dry carcasses of insects to establish a new protocol for necropsy
in support of a diagnosis of toxicity of ivermectin in dung beetles that die in the field. In this
case, we selected Scarabaeus cicatricosus and S. sacer Linnaeus, 1758, which was selected due to
its high frequency of mortality that is observed in the field (JRV personal observations). This
new method was applied for the detection of ivermectin in 36 post-mortem samples of Scara-
baeus cicatricosus and S. sacer carcasses that were collected from a site where ivermectin is
used as a veterinary pharmaceutical treatment for cattle.
Materials and methods
Standards and chemicals
The Abamectin (98.7%) and ivermectin (90% B1a; 5% B1b) standards were provided by Sigma
Aldrich (St. Louis, USA), and they were stored at –20˚C. Abamectin, a precursor to ivermectin,
Table 1. Comparison of methods and performance metrics for the determination of ivermectin in different biological and inorganic matrices.
Matrix Aliquots Method Extraction Clean-up r LLOQ Recovery (%) Ref.
Animal (mammal)
tissue
2 g HPLC-FLD Acetonitrile SPE alumina 0.999 1.0 70–80 [15]
Animal (mammal)
tissue
2.5 g HPLC-FLD Acetonitrile SPE alumina + C18 0.999 2.0 86–97 [16]
Animal (mammal)
tissue
5 g LC-MS; LC-FLD Acetonitrile + water LTP 0.99 1.0–
2.0
96–100.7 [17]
Animal (mammal)
tissue
2.5 g HPLC/APCI-MS/
MS
Acetonitrile SPE C8 0.997 NA 72.3 [18]
Animal (mammal)
tissue
1 g LC/ESI-MS/MS Ethanol LLE NA NA NA [19]
Animal (mammal)
plasma
500 μl LC/ESI-MS/MS Acetonitrile SPE C18 0.9989 1.0 NA [20]
Human plasma 200 μl HPLC-FLD Acetonitrile + water SPE Oasis 0.9992 0.2 86 [21]
Plant-based matrices 5 g LC/ESI-MS Acetonitrile SPE alumina 0.999 0.53 89–102 [22]
Dairy products 5 ml LC/ESI-MS Carrez’s reagent + methanol on-line SPE 0.998 2.11 82–88 [23]
Dairy products 0.5–1.0
g
HPLC-FLD Acetonitrile + ethyl acetate
+ water
LLE 0.998 0.16 84.6–106.5 [24]
Dairy products 5 g LC/ESI-MS/MS Acetonitrile + methanol LLE 0.999 0.2 92–100 [25]
Edible oils 2.5 g LC-MS/MS Acetonitrile LTP 0.99 1.1–
0.3
71.1–119.3 [26]
Foodstuffs 2.5 g HPLC-FLD Acetonitrile LLE 0.99 NA 67.9–88.9 [27]
Water, sediment and
soil
1–5 g HPLC/APCI-MS/
MS
PLE methanol + water SPE alox-N; C18;
Oasis
0.99 0.5–
2.5
73–81 [28]
Reindeer feces 1 g HPLC-FLD Acetone + isooctane SPE C18 NA NA 95–116 [29]
Cattle feces 15 ml HPLC-FLD Acetone + isooctane SPE C18 NA 2 84 [30]
Legend: (HPLC-FLD) High-performance liquid chromatography with fluorescence detection; (LC-MS) Liquid chromatography–mass spectrometry;
(LC-FLD) Liquid chromatography with fluorescence detection; (HPLC/APCI-MS/MS) High-performance liquid chromatography–atmospheric pressure
chemical ionization–tandem mass spectrometry; (LC/ESI-MS/MS) liquid chromatography-electrospray ionization-tandem mass spectrometry; (PLE)
pressurized liquid extraction; (SPE) solid-phase extraction; (LTP) temperature purification; (LLE) liquid–liquid extraction; (r) linearity, the correlation
coefficient; (LLOQ) lower limit of quantification, expressed in ng ml-1; (NA) not available.
doi:10.1371/journal.pone.0172202.t001
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differs from ivermectin in that it has a double-bond at the C22–23 position, and it was used as an
internal standard (IS). Acetonitrile and methanol (HPLC grade) were supplied by Panreac (Bar-
celona, Spain). Oasis-HLB1 sorbent was obtained from Waters Corporation (Milford, Massa-
chusetts, USA). Ammonium formate and formic acid (analytical reagent grade) were purchased
from Merck (Darmstadt, Germany). Millex-LG filter units (hydrophilic, PTFE, pore
size = 0.20 μm, diameter = 25 mm, filtration area = 3.9 cm2) were obtained from Millipore Ibe´r-
ica. Water was purified by passage through a Milli-Q system (Millipore Ibe´rica, Madrid, Spain).
To prepare the stock solutions, approximately 10.0 mg ± 0.01 mg of ivermectin and abamectin
reference standards were accurately weighed into individual 100 ml volumetric flasks and dis-
solved using methanol, to prepare two standard solutions of 100 μg ml–1 for ivermectin and aba-
mectin. Then, the appropriate aliquots were obtained and further diluted with methanol to give a
series of working solutions with a concentration ranging from 0.1 to 1000 ng ml–1. The IS work-
ing solution concentration was 5 ng ml–1. All the solutions were stored in a freezer at –20˚C.
Dung beetles and sampling design
Dung beetles (Scarabaeus cicatricosus and S. sacer) were collected from the Doñana Biological
Reserve (DBR-ICTS), an ivermectin-free site within the Doñana National Park (Huelva), in
Southern Spain during the summer (July 2014).
For ivermectin detection in the hemolymph and excretes of beetles, only individuals of the
most abundant species, Scarabaeus cicatricosus, were collected. Individuals were maintained in
plastic containers (60 × 40 × 40 cm) with moist sterile vermiculite as the substrate at 28–30˚C
in a climate-controlled chamber (a temperature similar to the optimal one experienced in the
field). For this bioassay, two concentrations of fresh cow dung-ivermectin, 1.0 (ivermectin T1)
and 100.0 (ivermectin T100) μg kg–1, and an untreated control were used. Previously, dung
ivermectin concentrations were achieved by dissolving ivermectin in absolute ethanol (Sigma-
Aldrich Co.), and 2 ml aliquots of the two selected concentrations were added to 2 kg portions
of fresh cow dung and mixed for 20 min using a kitchen mixer. For the untreated control,
absolute ethanol (2 ml) was applied to the same quantity of dung. Residual ethanol was
removed by evaporation during the 6 hours before transferring the dung treatments to the
individual experimental units. To identify ivermectin in the hemolymph and excretes, 10 indi-
viduals were fed 4 ml of both dung treatments. The beetles in the control group (N = 10) were
treated identically to the treatment groups but they were fed the free ivermectin dung. After
three days, the dung that was not consumed was removed, and a new portion of the corre-
sponding dung treatment was added. Twenty days post-treatment, all animals were allocated
to collecting hemolymph. A one-way ANOVA test was used to analyze possible differences in
the concentration of ivermectin between the T1 and T100 treatments.
For post-mortem analysis, the dung beetles carcasses (from both Scarabaeus species) that were
observed in the field were collected in July and October 2014 from Los Sotos, a site within the
Doñana National Park where ivermectin is used as a veterinary pharmaceutical treatment for cattle
and the dead dung beetles in close proximity to dung have been observed periodically. The beetle
carcasses were transported individually in plastic vials, identified and stored at −20˚C until analysis.
This work conforms to the Spanish legal requirements including those relating to conserva-
tion and welfare. Moreover, beetle collection was conducted with relevant permission related
to collection and field study.
Sample preparation and extraction
The sample preparation technique varied based on the sample nature. A flow diagram for the
protocol is presented in Fig 1.
Detection of ivermectin in dung beetles
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Fig 1. Schematic overview of methods used to determine ivermectin levels in different insect matrices. (A) Sample
preparation in hemolymph and excretes (in vivo samples) and dry carcasses of dung beetles (post mortem samples); (B)
Sample extraction procedure, and (C) Continuous solid-phase extraction (V1: valve 1; V2: valve 2; W: waste).
doi:10.1371/journal.pone.0172202.g001
Detection of ivermectin in dung beetles
PLOS ONE | DOI:10.1371/journal.pone.0172202 February 16, 2017 5 / 15
For in vivo samples, hemolymph was collected by puncturing the cuticle on the dorsal side
of the abdomen and gently squeezing the insect. The exuded hemolymph was collected with a
sterile syringe. The amount of collected hemolymph equivalent to 3 individuals (*10 μl) was
placed into a glass vial with 200 μl of acetonitrile, protected from light and stored at −85˚C in
an ultrafreezer (SANYO Electric Co. Ltd, Japan). The beetles were frozen immediately after
collecting their hemolymph. Excreta were obtained from treated and untreated beetles every 3
days. Then, the excreta samples were placed individually into plastic vials and stored at −20˚C
until analysis. The sample excretes from each treatment were placed in a porcelain mortar in
which liquid nitrogen was poured, and after crushing, the sample was stored at −85˚C in an
ultrafreezer (SANYO Electric Co. Ltd, Japan).
For insect carcasses (see post-mortem samples in Fig 1), the Scarabaeus sacer samples were
prepared using only a carcass/sample; however, due to the lower mass of S. cicatricosus, in this
case two carcasses were required for each sample. Each sample was placed in a mixer (Taurus
50N, Spain) container in which liquid nitrogen was poured while it was crushed, and then they
were placed in an oven at 50˚C for 30 minutes. Approximately 1.0 ± 0.01 g of each sample equil-
ibrated at room temperature was placed in a 15 ml polypropylene centrifuge tube and extracted
with 4 ml of water and 6 ml of acetonitrile (see sample extraction in Fig 1B). Next, the mixture
was sonicated for 5 min in an ultrasonic bath (JP Selecta, Barcelona, Spain), and then the tubes
were shaken for 1 min in a vortex (REAX Control, Heidolph, Kelheim, Germany). The acetoni-
trile phase was separated by centrifugation on a Centrofriger BL-II apparatus (JP Selecta, Barce-
lona, Spain) at 1914 g for 10 min (4˚C). Immediately following centrifugation, the supernatant
layer was transferred to a clean tube where it was evaporated to dryness at 40˚C under a stream
of ultrahigh-purity N2.
Afterwards, the pre-concentration and clean-up of samples were performed using continuous
solid phase extraction (SPE) (Fig 1C). The continuous SPE technique used for the pretreatment
for samples was based on the methodology described by Azzouz et al. [34]. The continuous
solid-phase extraction (SPE) manifold used was assembled from a Gilson Minipuls-3 peristaltic
pump (Villiers-le-Bel, France) fitted with polyvinyl chloride (PVC) pumping tubes, two Rheo-
dyne 5041 injection valves (Cotati, CA, USA) and PTFE (3 mm I.D.) and laboratory-prepared
columns of variable length packed with each sorbent material. The Oasis-HLB1 sorbent col-
umns were conditioned by passing 1 ml of acetonitrile and 1 ml of purified water. Under these
conditions, the column remained active for more than 50 samples. In the preconcentration step,
5 ml of the pretreated sample was filtered to prevent the suspended particles from reaching the
continuous unit, and they were passed at 4 ml min−1 through the sorbent column (80 mg Oasis-
HLB1). Ivermectin was adsorbed and the sample matrix was sent to waste. The analytes were
eluted with 400 μl of acetonitrile in a glass vial. Then, this solution was filtered through a Milli-
pore PTFE 0.20 μm (Millex1 Syringe Filter Units, Sterile, 25/50/62 mm, Hydrophobic PTFE) fil-
ter and stored −20˚C until analysis in the dark.
LC/ESI+–MS/MS analysis
The LC/ESI–MS/MS system consisted of an Agilent HPLC system Type 1100 linked to an Ion
Trap MS analyzer (Esquire 6000 de Bruker Daltonics) equipped with an electrospray ion
source (ESI). The system was controlled with the software packages Agilent ChemStation (ver-
sion A.06.01, Agilent Technologies) and Bruker Daltonics esquire control (version 6.08, Bru-
ker Daltonics, Bremen, Germany). The data were processed with Data Analysis software
(version 3.2, Bruker Daltonics).
Chromatography was performed on a C18 Kinetex column (75 mm × 3.0 mm, 3.0 μm, Phe-
nomenex, USA) that was operated at 40˚C. The mobile phase solvent A was a solution of 0.1%
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(v/v) formic acid in water and solvent B was 0.1% (v/v) formic acid in acetonitrile. The column
flow rate was 0.25 ml min–1, the injection volume was 1 μl and the gradient elution timetable
was as follows: 0–10 min 50% A-50% B; 10–15 min, 100% B; 15–20 min 50%A-50%B.
One-third of the column eluent was sent via ESI to the Ion Trap detector. For MS/MS detec-
tion, electrospray was operated in the positive ion mode, and the ionization source parameters
were as follows: capillary voltage, 4.0 kV; octopole RF amplitude, 144.3 Vpp; cone voltage 40 V;
nebulizing gas pressure, 40 psi; drying gas flow rate, 9 l min–1; capillary exit voltage, 300 V; and
desolvation temperature, 350˚C. Instrument tuning was performed for ivermectin and abamec-
tin by direct infusion of a 1 μg ml–1 solution. The optimum collision energy in the MS/MS
mode for the protonated sodium adducts of the molecular ion for ivermectin (m/z 897.4) and
abamectin (m/z 895.4) was 40 eV. For quantitative purposes, the instrument was operated in the
multiple reaction monitoring (MRM) mode, scanning from 50 to 2000 m/z.
Method validation
The proposed method for the quantitative determination of ivermectin in post mortem and in
vivo tissues was validated by a set of established parameters. The linearity of the method was
evaluated using fortified ivermectin-free dung beetles. Six evenly distributed calibration stan-
dards of ivermectin B1a concentrations were used: 0, 0.1, 0.5, 5.0, 7.0 and 10.0 ng g
–1. A fixed
concentration of the abamectin (5 ng g–1) internal standard (IS) was added to the samples
immediately prior to the analysis. The peak area ratios between ivermectin B1a and the IS was
plotted against the concentration ratios and a linear regression was performed. The acceptance
criterion for the correlation coefficient (r) was r 0.98.
The limit of detection (LOD) was determined by considering a signal to noise (S/N) ratio of
3:1 and the limit of quantification (LOQ) was determined from the lowest concentration of
ivermectin (in spiked ivermectin free-insects), which followed the criteria of a signal-to-noise
ratio (S/N) of 10:1. Matrix-matched standard calibration curves were generated by preparing
insect carcasses as described above and then mixing them with standard solutions containing
ivermectin at a concentration ranging from 10 ng g–1 to 0.1 ng g–1. LOQ was established as the
lowest point of the calibration curve.
The recovery of ivermectin was assessed by analyzing ivermectin-free insects that were
spiked at two concentrations 0.6 and 6.0 ng g–1 in triplicate. The recoveries were determined
by extrapolating the analyte concentrations from the calibration curves.
Results and discussion
A new analytical method was developed based on continuous solid-phase extraction to detect
ivermectin in post-mortem and in vivo tissues of dung beetles using LC-ESI-MS/MS. The
extraction step and clean up using an acetonitrile-water mix resulted in a clean extract. The
method described in this paper requires a short extraction time and small volumes of solvents
using small quantities of sample.
Optimization of extraction procedure and method validation
Various solvents, including acetonitrile [17,22] or ethanol [21] have been extensively used for
extracting ivermectin residues from biological samples. The selection of the solvent therefore
depends on not only the target compound, but also the matrix and in the present study, after
optimization of the extraction conditions, the optimal extraction solvent consisted of acetoni-
trile and distilled water at a ratio of 3:2 (v:v). Extraction using an acetonitrile-water (60:40, v/v)
mixture was highly efficient, with minor interference from impurities, and that mixture was
selected as the extraction solvent in the following work. The mixture was also used as the
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solvent for the extraction of the spiked insect tissue samples (6.0 and 0.6 ng g−1 fortification
level). In order to avoid the problems associated to IMV contamination from previous sam-
ples, it was checked by analyzing blank samples of 4 ml of ultrapure water every 3 samples
analysis. No carry-over was observed from the sorbent material during the tests in the method.
The results of the method validation are summarized in Table 2. All the validation parame-
ters indicated that the protocol to detect ivermectin in dung beetle tissues (for living and dead
beetles) and hemolymph was highly precise, sensible and reproducible (see Table 1 for a review
of the different analytical procedures). The samples that were spiked at two different concen-
tration levels (0.6 and 6 ng g–1) exhibited a recovery percentage range (mean ± s.d.) from
91.1 ± 11.6% to 103.2 ± 6.4%, respectively. These results indicate that after the continuous SPE
extraction, ivermectin can be extracted completely from beetle tissue samples and that the
macrolides lactone loss is negligible during the whole analytical procedure. Furthermore, the
concentration detected by the instrument with a 3:1 S/N ratio is interpreted as the ivermectin
limit of detection, which is estimated to be 0.01 ng g–1. The concentration detected by the
instrument with a 10:1 S/N ratio is interpreted as the limit of quantification, and it is estimated
to be 0.1 ng g−1. This value is lower than the result in many of the previous studies (Table 1).
Finally, the calibration standards were run in triplicate and the calibration curve showed good
linearity in the range of 0.1 ng ml–1 to 10 ng ml–1 (r = 0.988). Six calibration standards distrib-
uted evenly over the concentration range of interest were analyzed and were run in triplicate.
LC-ESI-MS/MS optimization
The best LC-MS/MS ionization conditions were achieved using direct infusion electrospray
solvent (acetonitrile/water) ammonium formate buffer operated in negative and positive
mode. However, the positive ion signals were considerably larger than the negative ion signals,
and the signals were detectable at very low concentrations of ivermectin and internal standard
of abamectin (IS).
The chromatographic separation is shown in Fig 2. Under the chromatographic conditions
mentioned above in the materials and methods section, the retention times for ivermectin and
IS were 10.1 and 8.2 min, respectively. The total run time per single injection was less than 11
min. Fig 3 shows the full-scan MS/MS spectrum of ivermectin obtained in the positive ion
mode and using the tune parameters mentioned above. In ESI positive ion MS mode, the mass
spectra of ivermectin showed a principal peak at m/z 897.4 from [B1a+Na]+ rather than the
expected m/z 875 [B1a+H]+, and three main daughter ions at m/z = 753.3, 835.3 and 609.4
showed adducts with sodium as the additive peak, which has also been described in other stud-
ies [19,20]. For abamectin (IS) the m/z 895.7 ion was the most abundant and three additional
Table 2. Validation results for the determination of ivermectin B1a in dung beetle samples by LC-ESI+-MS/MS.
Parameters Validation results
Calibration curve Concentration range Correlation coefficient (r)
0.1 to 10 ng g–1 0.988
Lower limits Concentration range
Lower limit of detection (LLOD) 0.1 to 10 ng g–1 0.01 ng g–1
Lower limit of quantification (LLOQ) 0.1 to 10 ng g–1 0.1 ng g–1
Recovery of IVM added to carcass tissue Spiked with Recovery ± SD (%)
0.6 ng g–1 91.1±11.6
6 ng g–1 103.2±6.4
Specificity No interference of endogenous compounds
doi:10.1371/journal.pone.0172202.t002
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daughter ions were detected at m/z 833.4, 751.3 and 607.3 which match the reported data in
the positive ionization mode [19,20,22,23]. Those additional daughter ions were used for the
complete identification and quantification of ivermectin. For quantitative purposes, the instru-
ment was operated in the multiple reaction monitoring (MRM) mode using the daughter ions
at m/z 753.3, 835.4 and 607.3 for ivermectin and m/z 751.3, 833.4 and 605.2 for abamectin.
Ivermectin determination in vivo samples
Ivermectin was detected in all analyzed matrices: hemolymph extracted samples and dung bee-
tle excreta.
For hemolymph samples, ivermectin was detected in both beetle groups that were treated
with the selected standard doses (T1 and T100) of ivermectin (Fig 4). High quantities of iver-
mectin were detected in both treatments (T1: 10.47 ± 0.40 ng g−1; T100: 13.53 ± 2.20 ng g−1).
We observed a positive relation between ivermectin concentration in the treatment and the
quantity of ivermectin detected; however, no significant differences between both treatments
were found (F = 5.41, P = 0.06). No ivermectin was detected in any of the hemolymph samples
from the control group (N = 10).
For excreta samples, ivermectin was determined in both beetle groups that were treated
with the selected standard doses (T1 and T100) of ivermectin (Fig 3). Compared with the
hemolymph samples, smaller quantities of ivermectin were determined in both treatments
(T1: 0.33 ± 0.11 ng g−1; T100: 0.35 ± 0.03 ng g−1). No significant differences between both
treatments were found (F = 0.08, P = 0.795).
Despite the 100-fold higher dose, the concentration in hemolymph and excreta from the
T100 samples was not significantly higher than the 10-fold lower concentration (T1).
Fig 2. LC-ESI+-MS/MS total ion chromatogram: abamectin (Retention time: 8.2 min) and ivermectin
B1a (Retention time: 10.1 min).
doi:10.1371/journal.pone.0172202.g002
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Furthermore, the ivermectin concentration in hemolymph was approximately 10-50-fold
higher than in the respective excreta extract. This interesting result could suggest the potential
Fig 3. ESI tandem mass spectrum of ivermectin B1a showing a peak at m/z 897.4 corresponding to
[B1a+Na]+ ivermectin.
doi:10.1371/journal.pone.0172202.g003
Fig 4. Ivermectin determination in hemolymph and excretes of Scarabaeus cicatricosus. Mean (±s.d)
data showing ivermectin concentrations in T1 and T100 treatments.
doi:10.1371/journal.pone.0172202.g004
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bioaccumulation of ivermectin in dung beetles as occurs in other invertebrate species such as
Lumbriculus variegatus [37]. The pharmacokinetic properties of ivermectin affect the function
of each species in which the compound is studied [38]. Surprisingly, no data exist about the
pharmacokinetics of ivermectin in dung beetles, which explains why this new analytical
method could be the basis for future studies about the pharmacokinetics and bioavailability of
this drug in different dung beetle species and other affected insects. Because the available infor-
mation about the metabolites and products of ivermectin in insects is not sufficient, further
research is needed to determine transformation products of ivermectin, such as the monosac-
charide (22,23-dihydroavermectin B1 monosaccharide) and the aglycon of ivermectin
(22,23-dihydroavermectin B1 aglycon) [39].
Ivermectin determination in post mortem samples
A total of 36 dead Scarabaeus cicatricosus (N = 18) and S. sacer (N = 18) beetles were found in the
field. In all cases the carcasses were intact without any indications of death caused by crushing or
predatory attack. The time of death was not determined with precision but in all cases it was
more than one week. The time of death surpassed three months in only one case (for S. sacer). In
all cases, ivermectin was detected in dead beetles with the exception of only one S. cicatricosus.
The concentration of ivermectin in carcass tissues was (mean ± SD, in ng g−1) 0.59 ± 0.55 and
0.80 ± 0.60 for Scarabaeus cicatricosus and Scarabaeus sacer, respectively (Fig 5). This result sug-
gests that the new analytical method is a useful tool to establish a new protocol to study the
impact of ivermectin on non-target arthropods such as dung beetles and other insects that are
related with the “dung community”. According to our results, ivermectin residues remain in the
insect carcasses, which is likely due to the function of the insect cuticle in preventing the passage
of ultraviolet rays that are capable of ivermectin transformation. As mentioned above, a S. sacer
carcass was found that had been dead for three months, and ivermectin was detected in the car-
cass (Fig 5). Thus, the high resistance of the ivermectin molecule together with the
Fig 5. Ivermectin determination in carcasses of Scarabaeus sacer and S. cicatricosus. Mean (±s.d) data
showing ivermectin concentrations in both species (red filled dots). Unfilled red dots correspond to individual
samples; unfilled blue dot corresponds to individual of S. sacer in which the time of death exceeded three
months. In all cases, samples were directly collected in the field (partially dehydrated by field conditions).
doi:10.1371/journal.pone.0172202.g005
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physiochemical nature of the insect cuticle enables drug detection in the carcasses of dung bee-
tles for a long period of time.
Conclusions
To the best of our knowledge, the proposed method is the first published qualitative and quan-
titative method for the determination of ivermectin B1a in insect tissues using LC-ESI
+-MS/
MS. A clear drawback of living organism’s sample-preparation procedures is the occurrence of
abundant matrix effects, which compromise quantification limits, analysis time and therefore
analysis costs. The developed method allows the detection and quantification of ivermectin in
very complex biological matrices that are present at trace levels with high extraction recoveries,
accuracy and sensitivity using the continuous solid phase extraction procedure. SPE in car-
tridge is frequently used as a clean-up technique in the simultaneous analysis of IVM in matrix
of animal origin, but selective wash steps and a selective elution can be used effectively to sepa-
rate the target compounds from matrix interferences [20,21,22,40]. Because in our study, the
chemical properties of the matrix (post morten dung beetle tissues hemolymph and excreta)
are very diverse, the options for clean up in SPE cartridges are limited. Although a simplified
extraction procedure was used, no interferences were observed from the matrix components
during the determination of ivermectin residues. The combination of the selected fast extrac-
tion technique with the use of continous SPE and LC-MS/MS permits the performance of the
analysis of IVM residues more simple, cost-effective (the column remains active for months)
and less time-consuming than traditional methods. Because satisfactory precision and accu-
racy values were obtained in both in vivo matrices, we suggest that the method can be consis-
tently used for quantitative determinations that are focused on future pharmacokinetic and
bioavailability studies in insects. Furthermore, this new analytical method was successfully
applied to biological samples of dead dung beetles from the field (post-mortem analysis).
Given that guidelines established by the International Cooperation on Harmonisation of Tech-
nical Requirements for Registration of Veterinary Medicinal Products (VICH; http://www.
vichsec.org/) require an environmental risk assessment when animal excreted residues such as
ivermectin are considered that adversely affect non-target organisms [10], we suggest that the
method can be used to establish a new routine analysis of ivermectin residues in insect car-
casses that is applied to complement typical mortality tests.
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